STERIS plc (STE)
USD 207.01
(-1.19%)
USD 207.01
(-1.19%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 5.13 Billion USD | 3.65% |
| 2023 | 4.95 Billion USD | 8.13% |
| 2022 | 4.58 Billion USD | 47.55% |
| 2021 | 3.1 Billion USD | 2.53% |
| 2020 | 3.03 Billion USD | 8.94% |
| 2019 | 2.78 Billion USD | 6.19% |
| 2018 | 2.61 Billion USD | 0.28% |
| 2017 | 2.61 Billion USD | 16.71% |
| 2016 | 2.23 Billion USD | 21.0% |
| 2015 | 1.85 Billion USD | 14.06% |
| 2014 | 1.62 Billion USD | 8.01% |
| 2013 | 1.5 Billion USD | 7.93% |
| 2012 | 1.39 Billion USD | 15.24% |
| 2011 | 1.2 Billion USD | -4.0% |
| 2010 | 1.25 Billion USD | -3.14% |
| 2009 | 1.29 Billion USD | 2.64% |
| 2008 | 1.26 Billion USD | 5.65% |
| 2007 | 1.19 Billion USD | 3.2% |
| 2006 | 1.16 Billion USD | 3.62% |
| 2005 | 1.11 Billion USD | 3.01% |
| 2004 | 1.08 Billion USD | 11.82% |
| 2003 | 972.08 Million USD | 12.16% |
| 2002 | 866.69 Million USD | 8.33% |
| 2001 | 800.08 Million USD | 5.19% |
| 2000 | 760.62 Million USD | -4.64% |
| 1999 | 797.6 Million USD | 10.83% |
| 1998 | 719.65 Million USD | 22.41% |
| 1997 | 587.9 Million USD | 544.63% |
| 1996 | 91.2 Million USD | 41.84% |
| 1995 | 64.3 Million USD | 40.39% |
| 1994 | 45.8 Million USD | 71.54% |
| 1993 | 26.7 Million USD | 106.98% |
| 1992 | 12.9 Million USD | 46.59% |
| 1991 | 8.8 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.34 Billion USD | 4.5% |
| 2024 FY | 5.13 Billion USD | 3.65% |
| 2024 Q3 | 1.39 Billion USD | 3.97% |
| 2024 Q4 | 1.41 Billion USD | 1.7% |
| 2024 Q1 | 1.28 Billion USD | -7.24% |
| 2023 FY | 4.95 Billion USD | 8.13% |
| 2023 Q2 | 1.2 Billion USD | 3.81% |
| 2023 Q1 | 1.15 Billion USD | -4.48% |
| 2023 Q3 | 1.21 Billion USD | 1.29% |
| 2023 Q4 | 1.38 Billion USD | 13.89% |
| 2022 Q1 | 968.42 Million USD | 10.86% |
| 2022 FY | 4.58 Billion USD | 47.55% |
| 2022 Q2 | 1.19 Billion USD | 23.6% |
| 2022 Q3 | 1.2 Billion USD | 1.0% |
| 2022 Q4 | 1.21 Billion USD | 0.14% |
| 2021 FY | 3.1 Billion USD | 2.53% |
| 2021 Q4 | 873.53 Million USD | 7.99% |
| 2021 Q1 | 668.93 Million USD | -18.72% |
| 2021 Q3 | 808.92 Million USD | 6.98% |
| 2021 Q2 | 756.13 Million USD | 13.04% |
| 2020 FY | 3.03 Billion USD | 8.94% |
| 2020 Q2 | 736.84 Million USD | 5.75% |
| 2020 Q3 | 774.26 Million USD | 5.08% |
| 2020 Q4 | 822.99 Million USD | 6.29% |
| 2020 Q1 | 696.8 Million USD | -9.3% |
| 2019 Q4 | 768.21 Million USD | 10.34% |
| 2019 Q3 | 696.23 Million USD | 2.54% |
| 2019 Q2 | 678.96 Million USD | 6.29% |
| 2019 FY | 2.78 Billion USD | 6.19% |
| 2019 Q1 | 638.75 Million USD | -10.78% |
| 2018 Q4 | 715.97 Million USD | 8.17% |
| 2018 FY | 2.61 Billion USD | 0.28% |
| 2018 Q3 | 661.9 Million USD | 4.37% |
| 2018 Q2 | 634.15 Million USD | 4.31% |
| 2018 Q1 | 607.96 Million USD | -10.75% |
| 2017 Q3 | 646.77 Million USD | 0.06% |
| 2017 FY | 2.61 Billion USD | 16.71% |
| 2017 Q1 | 638.37 Million USD | -7.52% |
| 2017 Q2 | 646.41 Million USD | 1.26% |
| 2017 Q4 | 681.18 Million USD | 5.32% |
| 2016 Q1 | 439.9 Million USD | -12.31% |
| 2016 Q2 | 489.89 Million USD | 11.37% |
| 2016 Q3 | 618.68 Million USD | 26.29% |
| 2016 Q4 | 690.27 Million USD | 11.57% |
| 2016 FY | 2.23 Billion USD | 21.0% |
| 2015 FY | 1.85 Billion USD | 14.06% |
| 2015 Q2 | 462.72 Million USD | 12.14% |
| 2015 Q1 | 412.64 Million USD | -11.31% |
| 2015 Q3 | 473.24 Million USD | 2.27% |
| 2015 Q4 | 501.64 Million USD | 6.0% |
| 2014 Q3 | 405.55 Million USD | 5.68% |
| 2014 Q4 | 465.28 Million USD | 14.73% |
| 2014 FY | 1.62 Billion USD | 8.01% |
| 2014 Q1 | 367.65 Million USD | -14.14% |
| 2014 Q2 | 383.76 Million USD | 4.38% |
| 2013 Q3 | 380.4 Million USD | 6.76% |
| 2013 Q4 | 428.21 Million USD | 12.57% |
| 2013 FY | 1.5 Billion USD | 7.93% |
| 2013 Q1 | 336.96 Million USD | -13.66% |
| 2013 Q2 | 356.32 Million USD | 5.75% |
| 2012 Q4 | 390.24 Million USD | 9.86% |
| 2012 Q1 | 318.63 Million USD | -15.65% |
| 2012 Q3 | 355.21 Million USD | 3.65% |
| 2012 FY | 1.39 Billion USD | 15.24% |
| 2012 Q2 | 342.7 Million USD | 7.55% |
| 2011 Q4 | 377.76 Million USD | 15.07% |
| 2011 Q1 | 188.98 Million USD | -43.1% |
| 2011 Q2 | 312.42 Million USD | 65.32% |
| 2011 Q3 | 328.28 Million USD | 5.08% |
| 2011 FY | 1.2 Billion USD | -4.0% |
| 2010 Q3 | 327.83 Million USD | 4.33% |
| 2010 FY | 1.25 Billion USD | -3.14% |
| 2010 Q2 | 314.22 Million USD | 10.82% |
| 2010 Q4 | 332.12 Million USD | 1.31% |
| 2010 Q1 | 283.54 Million USD | -17.66% |
| 2009 FY | 1.29 Billion USD | 2.64% |
| 2009 Q1 | 311.56 Million USD | -16.95% |
| 2009 Q4 | 344.36 Million USD | 7.79% |
| 2009 Q3 | 319.46 Million USD | -1.13% |
| 2009 Q2 | 323.12 Million USD | 3.71% |
| 2008 Q4 | 375.17 Million USD | 19.49% |
| 2008 FY | 1.26 Billion USD | 5.65% |
| 2008 Q2 | 295 Million USD | 5.0% |
| 2008 Q1 | 280.94 Million USD | -19.69% |
| 2008 Q3 | 313.97 Million USD | 6.43% |
| 2007 Q2 | 283.53 Million USD | 6.97% |
| 2007 Q3 | 298.96 Million USD | 5.44% |
| 2007 Q4 | 349.83 Million USD | 17.02% |
| 2007 FY | 1.19 Billion USD | 3.2% |
| 2007 Q1 | 265.06 Million USD | -19.99% |
| 2006 Q4 | 331.27 Million USD | 15.23% |
| 2006 Q2 | 284.37 Million USD | 2.77% |
| 2006 Q1 | 276.69 Million USD | -12.36% |
| 2006 Q3 | 287.49 Million USD | 1.1% |
| 2006 FY | 1.16 Billion USD | 3.62% |
| 2005 Q2 | 264.84 Million USD | 3.94% |
| 2005 Q3 | 284.38 Million USD | 7.38% |
| 2005 FY | 1.11 Billion USD | 3.01% |
| 2005 Q4 | 315.71 Million USD | 11.01% |
| 2005 Q1 | 254.79 Million USD | -13.94% |
| 2004 Q1 | 259.28 Million USD | -5.27% |
| 2004 Q3 | 274.28 Million USD | 6.56% |
| 2004 Q2 | 257.38 Million USD | -0.73% |
| 2004 Q4 | 296.05 Million USD | 7.94% |
| 2004 FY | 1.08 Billion USD | 11.82% |
| 2003 Q2 | 232.73 Million USD | 5.14% |
| 2003 Q3 | 244.31 Million USD | 4.98% |
| 2003 FY | 972.08 Million USD | 12.16% |
| 2003 Q1 | 221.35 Million USD | -9.5% |
| 2003 Q4 | 273.69 Million USD | 12.03% |
| 2002 Q3 | 218.63 Million USD | 5.93% |
| 2002 Q1 | 197.07 Million USD | -9.86% |
| 2002 FY | 866.69 Million USD | 8.33% |
| 2002 Q4 | 244.59 Million USD | 11.87% |
| 2002 Q2 | 206.39 Million USD | 4.73% |
| 2001 Q2 | 193.17 Million USD | 5.09% |
| 2001 FY | 800.08 Million USD | 5.19% |
| 2001 Q4 | 218.63 Million USD | 6.93% |
| 2001 Q1 | 183.81 Million USD | -3.32% |
| 2001 Q3 | 204.46 Million USD | 5.84% |
| 2000 Q4 | 190.12 Million USD | -2.55% |
| 2000 FY | 760.62 Million USD | -4.64% |
| 2000 Q3 | 195.1 Million USD | -1.76% |
| 2000 Q2 | 198.6 Million USD | 12.33% |
| 2000 Q1 | 176.8 Million USD | -22.08% |
| 1999 Q4 | 226.9 Million USD | 10.25% |
| 1999 FY | 797.6 Million USD | 10.83% |
| 1999 Q1 | 173.77 Million USD | -15.02% |
| 1999 Q2 | 191.1 Million USD | 9.97% |
| 1999 Q3 | 205.8 Million USD | 7.69% |
| 1998 Q3 | 186.63 Million USD | 7.65% |
| 1998 FY | 719.65 Million USD | 22.41% |
| 1998 Q1 | 155.13 Million USD | -9.01% |
| 1998 Q2 | 173.38 Million USD | 11.76% |
| 1998 Q4 | 204.5 Million USD | 9.57% |
| 1997 Q3 | 151 Million USD | 9.03% |
| 1997 Q1 | 127.9 Million USD | 399.61% |
| 1997 FY | 587.9 Million USD | 544.63% |
| 1997 Q4 | 170.5 Million USD | 12.91% |
| 1997 Q2 | 138.5 Million USD | 8.29% |
| 1996 Q2 | 21.6 Million USD | 9.09% |
| 1996 FY | 91.2 Million USD | 41.84% |
| 1996 Q4 | 25.6 Million USD | 5.79% |
| 1996 Q3 | 24.2 Million USD | 12.04% |
| 1996 Q1 | 19.8 Million USD | 1.02% |
| 1995 Q2 | 15.2 Million USD | 16.92% |
| 1995 Q3 | 16.5 Million USD | 8.55% |
| 1995 Q4 | 19.6 Million USD | 18.79% |
| 1995 FY | 64.3 Million USD | 40.39% |
| 1995 Q1 | 13 Million USD | -9.09% |
| 1994 Q2 | 10.5 Million USD | 15.38% |
| 1994 Q4 | 14.3 Million USD | 19.17% |
| 1994 Q3 | 12 Million USD | 14.29% |
| 1994 Q1 | 9.1 Million USD | 3.41% |
| 1994 FY | 45.8 Million USD | 71.54% |
| 1993 Q1 | 5 Million USD | 6.38% |
| 1993 FY | 26.7 Million USD | 106.98% |
| 1993 Q2 | 6.2 Million USD | 24.0% |
| 1993 Q3 | 6.8 Million USD | 9.68% |
| 1993 Q4 | 8.8 Million USD | 29.41% |
| 1992 Q2 | 2.5 Million USD | 8.7% |
| 1992 Q4 | 4.7 Million USD | 38.24% |
| 1992 FY | 12.9 Million USD | 46.59% |
| 1992 Q1 | 2.3 Million USD | 4.55% |
| 1992 Q3 | 3.4 Million USD | 36.0% |
| 1991 FY | 8.8 Million USD | 0.0% |
| 1991 Q3 | 2.5 Million USD | 4.17% |
| 1991 Q1 | 1.6 Million USD | 0.0% |
| 1991 Q2 | 2.4 Million USD | 50.0% |
| 1991 Q4 | 2.2 Million USD | -12.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott Laboratories | 40.1 Billion USD | 87.188% |
| Allurion Technologies Inc. | 53.46 Million USD | -9510.977% |
| Artivion, Inc. | 354 Million USD | -1351.594% |
| Avanos Medical, Inc. | 673.3 Million USD | -663.211% |
| Butterfly Network, Inc. | 65.9 Million USD | -7697.725% |
| Butterfly Network, Inc. | 65.9 Million USD | -7697.725% |
| Bio-Rad Laboratories, Inc. | 2.67 Billion USD | -92.37% |
| Boston Scientific Corporation | 14.24 Billion USD | 63.914% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -72235.318% |
| CONMED Corporation | 1.24 Billion USD | -314.093% |
| Edwards Lifesciences Corporation | 6 Billion USD | 14.423% |
| Paragon 28, Inc. | 216.38 Million USD | -2274.751% |
| Glaukos Corporation | 314.71 Million USD | -1532.832% |
| Globus Medical, Inc. | 1.56 Billion USD | -227.624% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | -722.457% |
| Integer Holdings Corporation | 1.59 Billion USD | -221.838% |
| Medtronic plc | 32.36 Billion USD | 84.122% |
| Nevro Corp. | 425.17 Million USD | -1108.611% |
| Owlet, Inc. | 54.01 Million USD | -9414.351% |
| Penumbra, Inc. | 1.05 Billion USD | -385.46% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 5.54 Billion USD | 7.394% |
| Sonendo, Inc. | 43.86 Million USD | -11614.809% |
| Stryker Corporation | 20.49 Billion USD | 74.931% |
| Vapotherm, Inc. | 68.66 Million USD | -7383.291% |
| Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | 30.504% |